Newsletter
of the Whitaker Institute of Biomedical Engineering
University of California, San Diego October 2001 Vol. 8, No. 2
Newsletter
of the Whitaker Institute of Biomedical Engineering
University of California, San Diego
October 2001
Vol. 8, No. 2
|
Am. Society of Biomechanics Meeting WIBE Profile: Michael J. Heller WIBE Visiting Scientists/New PhD’s Bioengineering Seminar Schedule |
Industrial Profile: Genoptix Genoptix
is developing a revolutionary technology aimed at fundamentally changing the
nature of cellular analysis.
The cell represents the true point of integration for all biological
processes and genomic information.
In the post-genomics era, accessing and deciphering this information will
be key to the successful development of new drugs and the diagnosis and
treatment of disease.
No existing technology efficiently and comprehensively addresses the
enormous complexity of this information. Genoptix
proprietary Optophoresis™ technology is the only technology capable of
simultaneously analyzing, selecting and moving specific cells based on their
intrinsic optical dielectric properties. The technology utilizes lasers in the
near infrared wavelength range to create moving optical gradients which are used
to selectively characterize and separate cells based on these innate properties.
This approach represents the first practical method for probing the inner
workings of intact living cells without the need for any dyes, labels or other
markers, which fundamentally differentiates Genoptix technology from all other
current methodologies. This
technology allows for the determination of individual “Optophoretic
Constants” which provide cells with unique signatures and facilitate their
rapid characterization and separation another.
These Optophoretic Constants uniquely reflect the physiological state of
individual cells at the exact moment at which they are being analyzed, allowing
the researcher to simply and efficiently gather a wide spectrum of information,
from screening new drugs, to studying the expression levels of novel genes, to
creating new diagnostic products, even to monitoring cancer patients.
Genoptix technology provides a revolutionary way to link the intricate
mechanisms involving the living cell’s overall activity with uniquely
identifiable optophoretic parameters. For
more information about Genoptix, Inc., please contact Dr. William Butler at wbutler@genoptix.com.
Dr. Butler received his Ph.D. degree in Physics from UCSD in 1983 and is
Director of Advanced Research & Development for Genoptix, Inc.
|
